Pitcairn’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,423
| Closed | -$169K | – | 710 |
|
|
2025
Q1 | $169K | Buy |
12,423
+1,125
| +10% | +$15.3K | 0.01% | 691 |
|
|
2024
Q4 | $230K | Buy |
11,298
+39
| +0.3% | +$795 | 0.01% | 651 |
|
|
2024
Q3 | $328K | Buy |
+11,259
| New | +$328K | 0.02% | 562 |
|
|
2023
Q3 | – | Sell |
-7,051
| Closed | -$208K | – | 657 |
|
|
2023
Q2 | $208K | Buy |
+7,051
| New | +$208K | 0.02% | 614 |
|